Come up with a name for your new list and we'll add to it:
Naurex raised a round of funding on January 24, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Naurex is a biopharmaceutical company developing novel modulators of the NMDA receptor to treat challenging diseases of the central nervous system (CNS). The company's first-generation compound, GLYX-…